WallStreetZenWallStreetZen

NYSE: CBT
Cabot Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CBT past earnings growth

How has CBT's earnings growth performed historically?
Company
25.85%
Industry
19.68%
Market
61.16%
CBT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CBT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CBT's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CBT past revenue growth

How has CBT's revenue growth performed historically?
Company
-9.12%
Industry
3.39%
Market
16.96%
CBT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CBT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CBT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CBT earnings and revenue history

Current Revenue
$3.9B
Current Earnings
$441.0M
Current Profit Margin
11.2%
CBT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CBT Return on Equity

Current Company
36.6%
Current Industry
18.4%
Current Market
188%
CBT's Return on Equity (36.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CBT announces earnings.

CBT Return on Assets

Current Company
12.4%
Current Industry
6.3%
CBT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CBT Return on Capital Employed

Current Company
18.05%
Current Industry
11.4%
CBT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CBT vs Specialty Chemical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CBT$3.92B$667.00M$441.00M+3.26%+43.77%
ASH$2.14B$391.00M$163.00M-3.70%+22.60%
NEU$2.70B$604.33M$388.86M+3.34%+14.73%
ESI$2.33B$347.10M$118.10M+3.54%+8.01%
BCPC$922.44M$214.81M$108.54M+7.46%+6.65%
View Top Specialty Chemical Stocks

CBT earnings dates

Next earnings date
May 7, 2024

Cabot Earnings & Revenue FAQ

What were CBT's earnings last quarter?

On Invalid Date, Cabot (NYSE: CBT) reported Q4 2023 earnings per share (EPS) of $0.88, up 6.38% year over year. Total Cabot earnings for the quarter were $50.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $0.94.

If you're new to stock investing, here's how to buy Cabot stock.

What was CBT's earnings growth in the past year?

As of Q2 2024, Cabot's earnings has grown 25.85% year over year. This is 6.17 percentage points higher than the US Specialty Chemicals industry earnings growth rate of 19.68%. Cabot's earnings in the past year totalled $441.00 million.

What is CBT's earnings date?

Cabot's earnings date is Invalid Date. Add CBT to your watchlist to be reminded of CBT's next earnings announcement.

What was CBT's revenue last quarter?

On Invalid Date, Cabot (NYSE: CBT) reported Q4 2023 revenue of $958.00 million up 0.73% year over year. In the same quarter last year, Cabot's revenue was $965.00 million.

What was CBT's revenue growth in the past year?

As of Q2 2024, Cabot's revenue has grown -9.12% year over year. This is 12.51 percentage points lower than the US Specialty Chemicals industry revenue growth rate of 3.39%. Cabot's revenue in the past year totalled $3.92 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.